The role of cytokines in the pathophysiology of chronic liver diseases

International Journal of Clinical & Laboratory Research

Volumn 23, Issue 1-4, 1993, Pages 179-185

  Tign, Herbert ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Cytokines; Liver diseases

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

BIOSYNTHESIS; CHRONIC DISEASE; HUMAN; LIVER DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

CHRONIC DISEASE; HUMAN; INTERLEUKIN-1; INTERLEUKIN-6; LIVER DISEASES; TUMOR NECROSIS FACTOR;

EID: 0027137990     PISSN: 09405437     EISSN: 14344467     Source Type: Journal    
DOI: 10.1007/BF02592306     Document Type: Review

References (67)

1. Detection of circulating intercellular adhesion molecule-1 in chronic liver disease
2. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection
3. Effects of cytokines on the liver
4. Interleukin-1 receptor antagonist
5. Protection against endotoxic shock by a human tumor necrosis factor receptor immunoadhesion
6. Cytokines tumor, necrosis factor and interleukin-6 in experimental biliary obstruction in mice
7. Interferon-gamma, more of a cachectin than tumor necrosis factor
8. Connective tissue metabolism and hepatic fibrosis
9. Molecular cloning of the interleukin-1β converting enzyme
10. N-Amino- L-Arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin
11. Expression of tumor necrosis factor-α and transforming growth factor-β in acute liver injury
12. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases
13. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production
14. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis
15. Interleukin-1 and interleukin-1 antagonism
16. Blocking IL-1 interleukin-1 receptor antagonist in vitro and in vivo
17. The role of interleukin-1 in diesease
18. Nitric oxide inhibits bile canalicular contraction: a potential cholestatic mechanism (abstract)
19. Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients
20. TNF and TGF-β: the opposite sides of the avenue?
21. IL-1 receptor anatagonist therapy of hepatic fibrosis (abstract)
22. Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease
23. Interleukin-1 receptor blockade attenuates the host inflammatory response
24. TNF and the liver
25. Therapeutic potential of cytokine manipulation
26. Interleukin-6
27. Nitric oxide production by monocytes in alcoholic liver disease
28. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentration in chronic alcoholic patients
29. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor
30. Fibrogenetic cytokines: the role of immune mediators in the development of scar tissue
31. Molecular cloning and expression of the human 55kD tumor necrosis factor receptor
32. Interleukin-1 receptor antagonist (IL-1Ra) reduces collagen deposition in experimental hepatic, fibrosis (abstract)
33. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor
34. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis
35. Solube interleukin-2 receptor in acute viral hepatitis and chronic liver disease
36. Dysregulation of in vitro cytokine production by monocytes during sepsis
37. Nitric oxide as a secretory product of mammlian cells
38. Soluble forms of tumor necrosis factor receptor (TNF-Rs). The cDNA for the type 1 TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor
39. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
40. Tumors secreting human TNF/cachectin induced cachexia in mice
41. Fibroproliferation in liver disease: role of monocyte factors
42. Human neutrophil elastase releases a ligand-binding fragment from the 75-kD tumor necrosis factor (TNF) receptor
43. Molecular cloning and expression of a receptor for human necrosis factor
44. a human inhibitor of tumor necrosis factor α
45. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection
46. Anticachectin/tumor necrosis factor-α antibodies, attenuate development of cachexia in tumor models
47. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis
48. Role of nitric oxide in gastrointestinal and hepatic function and disease
49. Evidence for the involvement of interleukin-6 in experimental cancer cachexia
50. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes
51. Serum levels of cytokines in chronic liver diseases
52. Increased serum nitrite and nitrate in cirrhosis. Relationship to endotoxemia (abstract)
53. Liver endocytosis and Kupffer cells
54. Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation
55. Metabolic effects of chachectin/tumor necrosis factor are modified by site of production: cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia
56. Hyperglobulinaemia in liver disease
57. The pathophysiology of tumor necrosis factors
58. Hepatic expression of type A and type B receptors for tumor necrosis factor
59. Neopterin as marker for activation of cellular immunity: immunological basis and clinical application
60. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis?
61. Decreased interleukin-1 activity in culture supernatent of lipopolysaccharide-stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma
62. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease
63. Immunohistochemical studies of intrahepatic tumour necrosis factor α in chronic liver disease